SCHEMBL31508019

SCHEMBL31508019

Cc1nc([N+](=O)[O-])ccc1OC1CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.37
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
CYP19A1 P11511 4/20 0.36
MAPT P10636 5/20 0.35
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
PTGES O14684 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
PTGS1 P23219 1/20 0.35
CYP2C19 P33261 1/20 0.35
PTGS2 P35354 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35
SCD O00767 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8558796 0.78 KMT2A (0.47) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL8326193 0.78 ALDH1A1 (0.42) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL23207659 0.74 MEN1 (0.43) GPR119MEN1KMT2ASCDRORC
SCHEMBL26151331 0.74 FFAR4 (0.39) CYP19A1MAPTALDH1A1MEN1KMT2A
SCHEMBL2829457 0.73 ALDH1A1 (0.40) KDM4EGAAMAPTALDH1A1MEN1
SCHEMBL20150273 0.73 TXNRD1 (0.38) SCD
SCHEMBL8566610 0.72 NPC1 (0.44) CYP19A1MAPTALDH1A1MEN1KMT2A
SCHEMBL31508069 0.71 MCHR1 (0.51) GPR119RORCMCHR1
SCHEMBL31678144 0.71 IRAK4 (0.36) KDM4EGAACYP19A1IRAK4SCD
SCHEMBL38658157 0.71 IRAK4 (0.36) KDM4EGAACYP19A1IRAK4SCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12384773-B2 Thiazole compounds and methods of use thereof ARCUS BIOSCIENCES, INC. (US) 2025-08-12 US disclosed
WO-2025096979-A1 THIAZOLE COMPOUNDS AS KIT INHIBITORS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2025-05-08 WO disclosed
US-20250145606-A1 THIAZOLE COMPOUNDS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2025-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12384773-B2 Thiazole compounds and methods of use thereof TPMT, CYP11B2, ABAT GPR119 452/4885KDM4E 4753/4885GAA 158/4885
US-20250145606-A1 THIAZOLE COMPOUNDS AND METHODS OF USE THEREOF TPMT, CYP11B2, ABAT GPR119 452/4885KDM4E 4753/4885GAA 158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.